Skip to Content

Franklin International Equity R LMIRX

Medalist Rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 18.39  /  +0.99 %
  • Total Assets 223.6 Mil
  • Adj. Expense Ratio
    1.550%
  • Expense Ratio 1.550%
  • Distribution Fee Level High
  • Share Class Type Retirement, Medium
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment
  • Status Open
  • TTM Yield 1.98%
  • Turnover 34%

USD | NAV as of Mar 01, 2024 | 1-Day Return as of Mar 01, 2024, 11:16 PM GMT+0

Morningstar’s Analysis LMIRX

Will LMIRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Franklin International Equity R's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LMIRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 14.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

2.78 5.7 Mil
Healthcare

ASML Holding NV

2.30 4.7 Mil
Technology

Novartis AG Registered Shares

1.77 3.6 Mil
Healthcare

Invesco Shrt-Trm Inv Treasury Instl

1.70 3.5 Mil
Cash and Equivalents

Nestle SA

1.43 2.9 Mil
Consumer Defensive

Roche Holding AG

1.34 2.8 Mil
Healthcare

Shin-Etsu Chemical Co Ltd

1.13 2.3 Mil
Basic Materials

Allianz SE

1.13 2.3 Mil
Financial Services

L'Oreal SA

1.07 2.2 Mil
Consumer Defensive

UniCredit SpA

1.00 2.1 Mil
Financial Services